Добро пожаловать на наш сайт!
Welcome to our website!

Biodefence NATO Science for Peace and Security Series A: Chemistry and Biology 2011
phone + 998 98 126 74 06
skype fargals
email info@fargals.com
Biodefence NATO Science for Peace and Security Series A: Chemistry and Biology 2011
2011-01-01
F.G. Nazirov, R.A. Ibadov, Z.A. Shanieva, Т.Н. (Jgarova, Kh.A. Kamilov, Z.N. Mansurov, and P.G. Komirenko
 
New Anti-Microbial Treatment of Purulent-Inflammatory Lung Diseases in Patients Supported by Long-Term Artificial Ventilation of Lungs
 
 Abstract We analysed the spectrum of microbial agents causing bronchial-pulmonary  complications in 52 patients who underwent various surgical interventions and were supported  by long-term artificial ventilation of lungs. "FarGALS", a medication with high antimicrobial    activity developed and produced at V.Vakhidov Republican Specialised Centre of Surgery, was   used for the first time in the nebuliser therapy. In comparison with other antimicrobial agents,   the use of "FarGALS" has reduced complications of long-period artificial ventilation, justifying further investigations of this medication for the use in nebuliser therapy by intensive care units (ICU).